QPW
EWTX icon

Quantum Private Wealth’s Edgewise Therapeutics EWTX Stock Holding History

Quantum Private Wealth’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67M Buy
116,624
+10,600
+10% +$306K 1.13% 16
2025
Q4 		$2.63M Buy
106,024
+150
+0.1% +$3.01K 0.77% 27
2025
Q3 		$1.72M Buy
105,874
+5,100
+5% +$72.3K 0.5% 41
2025
Q2 		$1.32M Buy
100,774
+10,050
+11% +$145K 0.43% 43
2025
Q1 		$2M Buy
90,724
+17,200
+23% +$451K 0.76% 25
2024
Q4 		$1.96M Buy
73,524
+100
+0.1% +$3.18K 0.63% 34
2024
Q3 		$1.96M Buy
73,424
+6,650
+10% +$132K 0.66% 29
2024
Q2 		$1.2M Buy
66,774
+100
+0.1% +$1.74K 0.43% 47
2024
Q1 		$1.22M Buy
66,674
+3,455
+5% +$54.9K 0.45% 49
2023
Q4 		$692K Buy
63,219
+1,500
+2% +$10.5K 0.29% 79
2023
Q3 		$354K Buy
61,719
+500
+0.8% +$3.4K 0.17% 122
2023
Q2 		$474K Buy
61,219
+12,500
+26% +$105K 0.22% 99
2023
Q1 		$325K Buy
48,719
+11,461
+31% +$106K 0.18% 124
2022
Q4 		$333K Buy
37,258
+3,950
+12% +$37K 0.21% 114
2022
Q3 		$327K Buy
33,308
+10,437
+46% +$105K 0.2% 118
2022
Q2 		$182K Buy
22,871
+629
+3% +$4.75K 0.11% 161
2022
Q1 		$215K Buy
22,242
+2,890
+15% +$37.2K 0.09% 180
2021
Q4 		$295K Buy
+19,352
New +$348K 0.11% 158

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Quantum Private Wealth's EWTX Position: Q1 2026 in Review

Quantum Private Wealth increased its Edgewise Therapeutics (EWTX) stake by 10% in Q1 2026, buying an estimated $306K and bringing the position to 116,624 shares worth $3.67M. The position accounts for 1.13% of the portfolio, ranked #16.

Quantum Private Wealth first reported a position in EWTX in Q4 2021 and has held it in 18 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Quantum Private Wealth held 116,624 shares of Edgewise Therapeutics worth $3.67M as of Q1 2026.
  • Quantum Private Wealth bought 10,600 Edgewise Therapeutics shares in Q1 2026, an estimated $306K.
  • Edgewise Therapeutics made up 1.13% of Quantum Private Wealth's portfolio in Q1 2026, its #16 holding.
  • Quantum Private Wealth first reported a position in Edgewise Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Quantum Private Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.